Anticoagulant Activity
Hirudin is a potent direct thrombin inhibitor, binding irreversibly to thrombin (a key enzyme in blood clotting). This prevents thrombin from converting fibrinogen into fibrin, effectively blocking blood clot formation.
Antithrombotic Effects
It is used to prevent or treat thrombosis (abnormal blood clots) in conditions like deep vein thrombosis (DVT), pulmonary embolism, or during surgeries requiring anticoagulation.
Cardiovascular Applications
Recombinant hirudin (e.g., lepirudin) has been studied for use in acute coronary syndromes (e.g., heart attacks) and to reduce clotting complications in procedures like angioplasty.
Anti-inflammatory Properties
Hirudin may modulate inflammation by inhibiting thrombin-mediated activation of platelets and inflammatory cells, potentially aiding in conditions like sepsis or inflammatory diseases.
Research Tool
In laboratories, hirudin is used to study clotting mechanisms, thrombin interactions, and to develop new anticoagulant drugs or biomaterials (e.g., coatings for medical devices).
Alternative to Heparin
Unlike heparin, hirudin does not require antithrombin III to function and is less likely to cause heparin-induced thrombocytopenia (HIT), making it a safer option for certain patients.
Wound Healing
Some studies suggest hirudin derivatives may promote wound healing by regulating microcirculation and reducing excessive fibrin deposition in damaged tissues.
Cancer Research
Emerging research explores hirudin’s potential to inhibit tumor metastasis by interfering with thrombin’s role in cancer progression and angiogenesis.
